# Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema

> **NCT00994955** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital Schleswig-Holstein** · enrollment: 39 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DEVICE:** selective retina therapy (SRT)

## Key facts

- **NCT ID:** NCT00994955
- **Lead sponsor:** University Hospital Schleswig-Holstein
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-12
- **Final completion:** 2009-10
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2013-01-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994955, "Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00994955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*